Skip to main content
Skip to main content
BMMJ logo

Body and Mind Inc. (BMMJ) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.0002 $0.00 (0.00%) |CouncilSplit View · 53 · B
Vol: 400| 52-wk range: $0.0001 – $0.01
Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Body and Mind Inc. (BMMJ) trades at $0.0002. Body and Mind Inc. cultivates, processes, distributes, and retails medical and recreational cannabis in multiple U.S. states. Sector: Healthcare.

Price as of Sep 11, 2026 · Last analyzed: Mar 16, 2026
Body and Mind Inc. cultivates, processes, distributes, and retails medical and recreational cannabis in multiple U.S. states. The company operates dispensaries and produces a range of cannabis products under the Body and Mind brand.

Analyst Coverage for BMMJ: BMMJ does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BMMJ against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the BMMJ film Every key number, told as a short cinematic story — just press play. ~2 min

Dated analysis: the newest financial statements on file are 28 months old (Apr 30, 2024), so the figures and score below describe that period, not today.

No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.

Council Score · Weighted Average of 3 Disciplines
Split View 53/100 · B

BMMJ: the 2 scored disciplines are evenly split. Dominant signal: Ray Dalio bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Englander-style lens (simulated)Izzy Englander
Favorable read
Klarman-style lens (simulated)Seth Klarman
Neutral read
Moon AI lens (model)
Neutral read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Weak
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Body and Mind Inc. (BMMJ) Healthcare & Pipeline Overview

CEOMichael Mills
Employees142
HeadquartersVancouver, CA
IPO Year2012

Body and Mind Inc. (BMMJ) is a cannabis company operating in the U.S., focusing on cultivation, processing, distribution, and retail of medical and recreational cannabis products. With operations in several states and a portfolio of branded products, BMMJ competes in the rapidly evolving cannabis market.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 16, 2026

What Is the Investment Thesis for BMMJ?

AI-written as of Mar 16, 2026 — figures and tone reflect the data available then, not today's score.

Body and Mind Inc. presents a speculative investment opportunity within the expanding U.S. cannabis market. Key value drivers include the company's multi-state operational footprint and its branded product portfolio. Growth catalysts involve potential regulatory changes at the state and federal levels, which could expand market access and reduce operational constraints. However, the company's negative profit margin of -92.1% and reliance on OTC markets pose significant risks. The company's beta of -0.60 suggests a potential inverse correlation to the market. The ability to achieve profitability and navigate regulatory hurdles will be critical for long-term success.

Based on FMP financials and quantitative analysis

BMMJ Key Highlights

AI-written as of Mar 16, 2026 — figures and tone reflect the data available then, not today's score.

Operates in multiple U.S. states including Nevada, California, Arkansas, Ohio, and Michigan, providing geographic diversification.

  • Offers a range of cannabis products including flower, concentrates, edibles, and topicals under the Body and Mind brand.
  • Gross margin of 25.3% indicates potential for profitability improvements with scale and operational efficiencies.
  • Trades on the OTC market, which presents both opportunities and risks related to liquidity and regulatory oversight.
  • Market capitalization of $0.00B reflects its current valuation and growth potential in the cannabis sector.

Who Are BMMJ's Competitors?

BMMJ is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
MKKGY Merck KGaA $30.59 +0.33% $66.5B 499-signal
TAK Takeda Pharmaceutical Company Limited $18.11 -0.55% $57.6B 635-pillar
TEVA Teva Pharmaceutical Industries Limited $36.65 +0.84% $42.7B 605-pillar
HLN Haleon plc $9.22 -0.11% $40.6B 775-pillar
SDZNY Sandoz Group AG $81.08 -2.68% $35.1B 519-signal
ZTS Zoetis Inc. $72.89 -0.57% $30.6B 855-pillar
SGIOY Shionogi & Co., Ltd. $9.04 +0.22% $15.4B 619-signal
ELAN Elanco Animal Health Incorporated $22.86 -2.93% $11.4B 335-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are BMMJ's Key Strengths?

Vertically integrated operations.

  • Multi-state presence.
  • Established brand recognition.
  • Diverse product portfolio.

What Are BMMJ's Weaknesses?

Negative profit margin.

  • Reliance on OTC markets.
  • Limited financial resources.
  • High regulatory compliance costs.

What Could Drive BMMJ Stock Higher?

Potential changes in state and federal cannabis regulations could expand market access.

  • Expansion of operations into new states and markets.
  • Development and launch of new cannabis products.
  • Strategic partnerships and acquisitions to enhance market position.

What Are the Key Risks for BMMJ?

Financial-distress signal — its Altman Z-Score of -8.09 sits in the distress zone (elevated bankruptcy risk).

  • Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
  • Evolving regulatory landscape and compliance costs.
  • Intense competition in the cannabis industry.
  • Fluctuations in cannabis prices and market demand.
  • Limited access to capital and financing.
  • Negative profit margin and financial instability.

What Are the Growth Opportunities for BMMJ?

  • Expansion into New Markets: Body and Mind Inc. can pursue growth by expanding its operations into additional states as cannabis legalization progresses. Targeting states with favorable regulatory environments and high population densities could significantly increase revenue. The timeline for this expansion depends on legislative changes and the company's ability to secure licenses and establish operations in new jurisdictions. This strategy allows BMMJ to capture a larger share of the growing U.S. cannabis market.
  • Product Innovation and Development: Investing in research and development to create new and innovative cannabis products can drive growth. This includes developing new formulations, delivery methods, and product categories that appeal to a wider range of consumers. The timeline for product development varies depending on the complexity of the product and regulatory requirements. Successful product innovation can differentiate BMMJ from competitors and increase brand loyalty.
  • Strategic Partnerships and Acquisitions: Forming strategic partnerships with other cannabis companies or acquiring complementary businesses can accelerate growth. This includes partnerships with established brands, technology providers, or distribution networks. Acquisitions can provide access to new markets, technologies, or product lines. The timeline for partnerships and acquisitions depends on market opportunities and the company's financial resources. These strategic moves can enhance BMMJ's competitive position and market reach.
  • Increased Retail Footprint: Expanding the company's retail presence through new dispensaries or acquisitions can drive revenue growth. This includes opening new locations in existing markets or entering new markets with a strong retail presence. The timeline for retail expansion depends on regulatory approvals, real estate availability, and capital investment. A larger retail footprint can increase brand visibility and customer access to BMMJ's products.
  • Focus on Medical Cannabis Market: With an aging population and increasing acceptance of cannabis for medical purposes, BMMJ can focus on expanding its presence in the medical cannabis market. This includes developing products specifically tailored to medical patients and partnering with healthcare providers. The timeline for this strategy depends on regulatory changes and the company's ability to meet medical cannabis standards. A focus on the medical market can provide a stable revenue stream and differentiate BMMJ from competitors.

What Are BMMJ's Competitive Advantages?

  • Vertically integrated operations provide control over the supply chain.
  • Established brand recognition in key markets.
  • Multi-state operational footprint provides diversification.
  • Proprietary cultivation and processing techniques.

What Does BMMJ Do?

Body and Mind Inc., formerly known as Deploy Technologies Inc., was incorporated in 1998 and rebranded in November 2017 to focus on the cannabis industry. Headquartered in Vancouver, Canada, the company cultivates, processes, distributes, and retails medical and recreational cannabis in several U.S. states, including Nevada, California, Arkansas, Ohio, and Michigan. Its product offerings include packaged flower buds, concentrates, Gpen vaporizers, distillate oil cartridges, and distillate-infused edibles. The company produces and sells cannabis flower, oil, extracts, and edibles under its Body and Mind brand. BMMJ also operates the ShowGrow San Diego dispensary and manages the ShowGrow Long Beach dispensary. Additionally, it produces marijuana extract products, such as distillate oils, ice waxes, dry sifts, shatters, edibles, and topicals, catering to both medical and recreational users. The company's vertically integrated operations span cultivation to retail, allowing it to control product quality and supply chain.

What Products and Services Does BMMJ Offer?

  • Cultivates medical and recreational cannabis.
  • Processes cannabis into various forms, including concentrates and extracts.
  • Distributes cannabis products to dispensaries.
  • Retails cannabis products through company-owned and managed dispensaries.
  • Produces and sells cannabis flower, oil, extracts, and edibles under the Body and Mind brand.
  • Manufactures marijuana extract products like distillate oils, ice waxes, and shatters.
  • Offers a range of products including Gpen vaporizers and distillate oil cartridges.

How Does BMMJ Make Money?

  • Vertically integrated operations from cultivation to retail.
  • Generates revenue through the sale of cannabis products at dispensaries.
  • Wholesale distribution of cannabis products to other retailers.
  • Branding and licensing of the Body and Mind name.

What Industry Does BMMJ Operate In?

The U.S. cannabis industry is experiencing rapid growth, driven by increasing legalization and consumer acceptance. Body and Mind Inc. operates within this dynamic market, competing with both established players and emerging brands. The industry faces evolving regulations, varying state laws, and increasing competition. Companies like BMMJ must adapt to these changes while focusing on product innovation, operational efficiency, and market expansion.

Who Are BMMJ's Key Customers?

  • Medical cannabis patients seeking relief from various conditions.
  • Adult recreational cannabis users.
  • Wholesale customers including other dispensaries and retailers.
Model self-rating on this text: 71% (not a measure of the evidence) Updated: Mar 16, 2026

Research confidence

Low 23/100

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • Scoring coverage unknown
  • Price is current
  • Latest filing 813 days ago
  • No analyst coverage

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 39
2026-08-26 39
2026-08-29 39
2026-09-01 39
2026-09-04 39
2026-09-07 39
2026-09-10 39

What changed?

The score has stayed at 39.

Over the same 18 days the stock moved +0.0%.

Company Profile

Body and Mind Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Vancouver, CA. The company is led by CEO Michael Mills. BMMJ has traded publicly since 2012.

Body and Mind Inc. Financial Trajectory

Body and Mind Inc. (BMMJ) reported $4.4M in revenue for Q3 FY2024, a decline of 1.1% compared to the prior quarter. The company recorded a net loss of $2.6M, with diluted EPS of $-0.02.

Key Financial Metrics

Return on assets is -99.1%, showing how much profit it generates from its asset base. A current ratio of 1.21 indicates the company holds enough short-term assets to cover its near-term obligations.

F-Score 2/9

Financial Health

Body and Mind Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -8.09 places it in the distress zone, a signal of elevated financial risk.

Net buying

Insider Activity

The most recent 8 insider filings for Body and Mind Inc. break down as 0 sales and 8 purchases. On net that is roughly 9.0M shares acquired (about $574K) — insiders putting money in tends to read as conviction.

BMMJ Financials

Bull Case vs Bear Case

Bull Case

  • Vertically integrated operations.
  • Multi-state presence.
  • Established brand recognition.
  • Diverse product portfolio.

Bear Case

  • Negative profit margin.
  • Reliance on OTC markets.
  • Limited financial resources.
  • High regulatory compliance costs.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q3 FY2024 $4M -$3M -$0.02
Q2 FY2024 $4M -$3M -$0.02

Q3 FY2024 · filed 20 Jun 2024 · SEC EDGAR →

Based on FMP financials and quantitative analysis

BMMJ Latest News

BMMJ Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for BMMJ.

Price Targets

Wall Street price target analysis for BMMJ.

BMMJ MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for BMMJ; grades run from A+ (80-100) to F (below 30).

Leadership: Michael Mills

CEO

Michael Mills serves as the CEO of Body and Mind Inc., overseeing the company's operations and strategic direction. His background includes experience in management and leadership roles. He is responsible for guiding the company's growth and expansion in the competitive cannabis market. His leadership is crucial for navigating the complex regulatory environment and achieving profitability.

Track Record: Under Michael Mills' leadership, Body and Mind Inc. has expanded its operations into multiple states and developed a portfolio of branded cannabis products. He has focused on building a vertically integrated business model and increasing the company's retail presence. Key milestones include securing licenses in new jurisdictions and launching innovative product lines.

BMMJ OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Body and Mind Inc. may not meet the minimum financial standards required for higher tiers like OTCQB or OTCQX. Companies in this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and lower liquidity.

  • OTC Tier: OTC Other
Liquidity: Trading volume for BMMJ on the OTC market is likely to be low, which can result in wider bid-ask spreads and difficulty in buying or selling shares quickly. This limited liquidity can increase the risk of price volatility and make it challenging to execute large trades without significantly impacting the stock price. Investors should be aware of these liquidity constraints before investing.
OTC Risk Factors:
  • Limited financial disclosure.
  • Lower regulatory oversight.
  • Higher price volatility.
  • Potential for fraud or manipulation.
  • Limited liquidity.
Due Diligence Checklist:
  • Verify the company's financial statements.
  • Research the company's management team.
  • Assess the company's business model and competitive landscape.
  • Review the company's regulatory filings.
  • Evaluate the company's liquidity and trading volume.
  • Consult with a financial advisor.
  • Understand the risks associated with OTC investments.
Legitimacy Signals:
  • Operations in multiple U.S. states.
  • Established brand recognition.
  • Vertically integrated operations.
  • Presence in the cannabis industry since 2017.
  • Licensed cannabis operations.

BMMJ Healthcare Stock FAQ

Is BMMJ a good stock?

Stock Expert AI does not rate BMMJ buy, sell or hold. Body and Mind Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What do analysts say about BMMJ stock?

As of 2026-03-16, there is no readily available analyst consensus on Body and Mind Inc. (BMMJ) due to its OTC listing and smaller market capitalization. Key valuation metrics, such as the P/E ratio of -0.12 and a negative profit margin of -92.1%, suggest that the company is not currently profitable.

What are the main risks for BMMJ?

The main risks for Body and Mind Inc. include the evolving regulatory landscape of the cannabis industry, which can impact operational costs and market access. Additionally, the company's reliance on OTC markets and limited access to capital pose financial risks.

What are the key factors to evaluate for BMMJ?

Evaluate BMMJ on fundamentals, analyst consensus, and risk factors. Body and Mind Inc. presents a speculative investment opportunity within the expanding U.S. cannabis market. Not financial advice.

How frequently does BMMJ data refresh on this page?

BMMJ's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven BMMJ's recent stock price performance?

Body and Mind Inc. (BMMJ) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Vertically integrated operations. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider BMMJ overvalued or undervalued right now?

Body and Mind Inc. (BMMJ) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of BMMJ?

Yes, most major brokerages offer fractional shares of Body and Mind Inc. (BMMJ) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data and may be subject to change.
  • OTC market data may be limited and less reliable than exchange-listed data.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover